|
TMED5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.16019999455375E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.23919999986499E-07 |
| Normal-vs-Stage2 |
5.805100E-04 |
| Normal-vs-Stage3 |
1.055680E-02 |
| Normal-vs-Stage4 |
1.549770E-02 |
| Stage1-vs-Stage2 |
4.264000E-01 |
| Stage1-vs-Stage3 |
1.006430E-01 |
| Stage1-vs-Stage4 |
4.554200E-01 |
| Stage2-vs-Stage3 |
5.282400E-01 |
| Stage2-vs-Stage4 |
8.575400E-01 |
| Stage3-vs-Stage4 |
7.715800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.06760000839756E-09 |
| Normal-vs-AfricanAmerican |
1.217520E-04 |
| Normal-vs-Asian |
3.494800E-01 |
| Caucasian-vs-AfricanAmerican |
8.359800E-01 |
| Caucasian-vs-Asian |
3.945600E-01 |
| AfricanAmerican-vs-Asian |
3.651400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.23149999881656E-08 |
| Normal-vs-Female |
1.489510E-02 |
| Male-vs-Female |
1.235950E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.441500E-03 |
| Normal-vs-Extreme_Weight |
2.78389999941453E-08 |
| Normal-vs-Obese |
1.24059999995207E-06 |
| Normal-vs-Extreme_Obese |
1.755670E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.099000E-01 |
| Normal_Weight-vs-Obese |
8.280800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.648000E-01 |
| Extreme_Weight-vs-Obese |
3.338300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.939000E-01 |
| Obese-vs-Extreme_Obese |
7.659800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.654300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.408940E-04 |
| Normal-vs-Age(61-80Yrs) |
3.88500343007081E-11 |
| Normal-vs-Age(81-100Yrs) |
2.967800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.243800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.622420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.133200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.747800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.516000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.990800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.0702999981026E-08 |
| Normal-VS-Type2 PRCC |
4.835400E-03 |
| Normal-VS-KIRP CIMP |
4.744200E-01 |
| Normal-VS-Unclassified PRCC |
5.040400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.540800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.853600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.427900E-04 |
| Type2 PRCC-VS-KIRP CIMP |
3.852400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.001200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.921400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.29139999999395E-06 |
| Normal-vs-N1 |
1.587910E-02 |
| Normal-vs-N2 |
7.968200E-01 |
| N0-vs-N1 |
1.960200E-01 |
| N0-vs-N2 |
3.935800E-01 |
| N1-vs-N2 |
4.064200E-01 |
|
|
